Fevertree Drinks has been a regular presence on the regulatory news wires this autumn, publishing weekly notices of transactions in its own shares as it works through a £60 million buyback programme. The most recent, on 10 November 2026, followed a run of similar announcements stretching back through September and October, alongside holdings notifications and director share dealings.
What the company does
Fevertree is a premium drinks Brand best known for its tonic waters and mixers designed to be paired with spirits. The company outsources production and focuses on brand building, Marketing and distribution across its main markets, which include the UK, the United States and Europe. In recent years it has broadened its range beyond tonic, and non-tonic products accounted for 47% of group sales in the first half of 2026, according to its interim results.
Latest developments
The interim results for the six months to 30 June 2026, published on 10 September 2026, set the tone for the second half. Since then the newsflow has been dominated by the buyback, with transaction in own shares announcements released on 15, 22 and 29 September, 6, 13, 20 and 27 October, and 3 and 10 November. Total voting rights notices were issued on 1 October and 2 November, and the company also reported director and PDMR shareholdings on 14 September and 22 October. Holdings in company notices on 23 September, 16 October and 3 November indicate movements among larger investors on the share register.
Financial and Dividend picture
In the first half of 2026 Fevertree reported brand Revenue of £183.6 million, an increase of 8% at constant currency. The United States, which the company has long identified as its most important growth market, delivered revenue growth of 11%, while the UK Business returned to growth after a more difficult period. Adjusted EBITDA rose 9% to £20.1 million, despite higher marketing Investment in the US.
The company maintained its expectations for the full 2026 financial year and reported a cash position of about £68 million. That Balance Sheet strength supports the £60 million share buyback, which reduces the number of shares in issue and returns surplus Capital to investors. Details of the Interim Dividend were not available in the summary reviewed for this article, so readers should consult the full results statement for the company's dividend arrangements.
Sector and index context
Fevertree is one of the larger and more widely followed companies in the FTSE AIM All Share Index, and among the best-known consumer brands on the junior market. The premium mixer category has become more competitive since the company's early years of rapid growth, with established soft drinks groups and private label ranges seeking a share of the market. Consumer Demand for premium spirits and long drinks, and wider pressures on discretionary spending, have a direct bearing on the business.
Key risks
The group's reliance on the US for future growth exposes it to shifts in American consumer behaviour, competitive pressures and currency movements. Input costs such as glass, packaging and transport have weighed on margins in previous years and remain a sensitivity. Heavier marketing spending must translate into sustained Volume growth to justify the outlay, and any weakening in demand for premium spirits could affect mixer sales.
What to watch next
Investors will look to a year-end trading update, typically issued in January, for confirmation that full-year expectations have been met. Progress on the buyback, continued momentum in the US and the durability of the UK recovery are likely to be the main areas of focus, together with any update on gross Margin trends and marketing investment for 2027.





_11_19_2026_14_00_51_536296.jpg)
Please wait processing your request...